Immune-Inhibitory Gene Expression is Positively Correlated with Overall Immune Activity and Predicts Increased Survival Probability of Cervical and Head and Neck Cancer Patients

Background: Limited immunotherapy options are approved for the treatment of cervical cancer and only 10–25% of patients respond effectively to checkpoint inhibition monotherapy. To aid the development of novel therapeutic immune targets, we aimed to explore survival-associated immune biomarkers and...

Descripción completa

Detalles Bibliográficos
Autores principales: Budhwani, Megha, Turrell, Gavin, Yu, Meihua, Frazer, Ian H., Mehdi, Ahmed M., Chandra, Janin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021786/
https://www.ncbi.nlm.nih.gov/pubmed/33834038
http://dx.doi.org/10.3389/fmolb.2021.622643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021786/
https://www.ncbi.nlm.nih.gov/pubmed/33834038
http://dx.doi.org/10.3389/fmolb.2021.622643

Ejemplares similares